IPAMORELIN - Research Grade Peptide

IPAMORELIN – Research-Grade Synthetic Pentapeptide

For research purposes only. This product is supplied exclusively for scientific laboratory research and analytical purposes. It is not intended for human or animal use, consumption, clinical use or therapeutic application. It must not be used in any way that contravenes applicable laws or the requirements of the Medicines and Healthcare products Regulatory Agency.

• Research-grade synthetic pentapeptide with batch documentation available where supplied
• Defined modified sequence comprising five amino-acid and non-proteinogenic amino-acid residues
• Supplied as lyophilised laboratory material in sealed flip-top headspace vials
• Batch identity, chromatographic purity, peptide content and analytical specifications stated in the applicable Certificate of Analysis
• Handled and supplied exclusively as a research-use laboratory material

All of our research peptides and related laboratory materials are supplied strictly for scientific research and laboratory use only. Each vial contains lyophilised material prepared to support controlled laboratory handling and storage. The stated nominal amount refers to the declared Ipamorelin peptide content of a single vial, subject to the applicable batch documentation. Where dissolution or reconstitution is required, the solvent, buffer, concentration, handling procedure and storage conditions stated in the applicable Certificate of Analysis, Safety Data Sheet or validated laboratory method should be followed. We do not provide advice or recommendations concerning dosage, administration or use in humans or animals.

Chemical Information:

• Product Name: IPAMORELIN
• Alternative Names: Ipamorelin; NNC 26-0161; NNC-26-0161
• Chemical Classification: Synthetic modified pentapeptide
• Sequence Length: Five amino-acid and non-proteinogenic amino-acid residues
• Peptide Sequence: H-Aib-His-D-2-Nal-D-Phe-Lys-NH₂
• Expanded Sequence: 2-aminoisobutyryl-L-histidyl-3-(2-naphthyl)-D-alanyl-D-phenylalanyl-L-lysinamide
• Non-Proteinogenic Residue: Aib denotes 2-aminoisobutyric acid, also known as 2-methylalanine
• Aromatic Residue: D-2-Nal denotes 3-(2-naphthyl)-D-alanine
• Stereochemical Features: Contains D-2-naphthylalanine and D-phenylalanine residues
• N-Terminal Structure: Free Aib amino terminus
• C-Terminal Structure: C-terminal lysinamide
• Ipamorelin Free-Form CAS Number: 170851-70-4
• PubChem Compound Identifier: CID 9831659
• Unique Ingredient Identifier: Y9M3S784Z6
• Free-Form Molecular Formula: C₃₈H₄₉N₉O₅
• Free-Form Average Molecular Weight: Approximately 711.86 g/mol
• InChIKey: NEHWBYHLYZGBNO-BVEPWEIPSA-N
• Ipamorelin Acetate CAS Number: 1258196-85-8
• Ipamorelin Acetate General Formula: C₃₈H₄₉N₉O₅ · xCH₃COOH
• Ipamorelin Acetate Molecular Weight: Dependent upon the measured acetate stoichiometry; refer to the applicable batch Certificate of Analysis
• Physical Form: Lyophilised laboratory material, as stated in the applicable batch Certificate of Analysis
• Appearance: Refer to the applicable batch Certificate of Analysis
• Chemical-Form Confirmation: The applicable Certificate of Analysis should identify whether the supplied material is Ipamorelin free form, Ipamorelin acetate or another counter-ion form
• Counter-Ion Confirmation: Acetate, trifluoroacetate or another counter-ion may affect the measured formula weight, water content and net peptide content of the supplied material
• Purity Specification: The applicable chromatographic purity result, analytical method and acceptance criterion are stated in the batch Certificate of Analysis
• Peptide-Content Specification: Net peptide content should be distinguished from chromatographic purity and interpreted alongside water, counter-ion and residual-solvent results
• Identity Confirmation: Product identity should be supported by sequence documentation and mass-spectrometry results consistent with the specified Ipamorelin molecular structure
• Aggregation and Impurity Control: Peptide aggregation, individual peptide-related impurities, synthesis-related impurities and process-related impurities are separate quality attributes and are not established by a chromatographic purity percentage alone
• Endotoxin Specification: The applicable bacterial endotoxin or LPS result, analytical method, reporting units and acceptance limit should be stated in the batch Certificate of Analysis
• Analytical Interpretation: Molecular identity, stereochemistry, chromatographic purity, net peptide content, aggregation, water content, residual solvent content, counter-ion content and bacterial endotoxin results are separate analytical measurements and should be interpreted together

✓ Batch documentation – Completed Certificate of Analysis documentation is provided where supplied for review.
✓ Certificate of Analysis – Accessible through the product QR code where provided for the applicable batch.
✓ Safety Data Sheet – Supplied to support appropriate laboratory handling, storage and regulatory compliance.
✓ Sequence documentation – The modified pentapeptide sequence, stereochemistry and molecular identity should be confirmed using the applicable batch records.
✓ Mass-spectrometry documentation – Molecular identity should be supported by analytical mass data consistent with the specified Ipamorelin structure.
✓ Purity documentation – The reported chromatographic purity applies only to the analytical method and batch stated in the Certificate of Analysis.
✓ Peptide-content documentation – Net peptide content should be distinguished from chromatographic purity and interpreted alongside water, counter-ion and residual-solvent results.
✓ Chemical-form documentation – The free form, acetate form or other counter-ion form should be identified clearly in the applicable product and batch records.
✓ Bacterial endotoxin documentation – The applicable bacterial endotoxin or LPS result should identify the test method, reporting units and acceptance criterion.
✓ Supplier documentation – Reviewed where supporting synthesis, purification and analytical records are supplied.
✓ Fast, reliable and trackable express delivery – Securely packaged and dispatched using insulated or temperature-managed packaging where required by the applicable transport and storage specification.

For Research Use Only
This product is supplied strictly for scientific research, laboratory analysis and experimental work. It is not intended for human consumption, animal use, clinical use, diagnostic use or any form of therapeutic application.

Ipamorelin Product Overview

Our Ipamorelin research-grade synthetic pentapeptide is supplied for controlled scientific laboratory investigation, analytical method development, peptide characterisation, high-performance liquid chromatography assessment and mass-spectrometry workflows. The material comprises a defined modified sequence of five residues incorporating 2-aminoisobutyric acid, D-2-naphthylalanine and D-phenylalanine, together with a C-terminal lysinamide.

The material is handled with a focus on batch traceability, documented quality control and consistent laboratory presentation. Product identity, stereochemistry, chromatographic purity, net peptide content, molecular form, counter-ion content, water content, residual solvents, aggregation, bacterial endotoxin results and other analytical specifications should be confirmed using the applicable batch Certificate of Analysis. Chromatographic purity should not automatically be interpreted as equivalent to the total net peptide content of the vial.

The CAS number 170851-70-4, molecular formula C₃₈H₄₉N₉O₅ and molecular weight of approximately 711.86 g/mol identify Ipamorelin free form. Where the supplied product is Ipamorelin acetate, the applicable batch documentation should instead identify the acetate form, acetate content and resulting batch-specific formula weight.

For the majority of routine analytical, investigative and general laboratory work, the Regular Ipamorelin specification remains highly suitable. The premium black-and-gold ULTIMATE Ipamorelin option provides an additional preparative high-performance liquid chromatography purification stage and a more stringent bacterial endotoxin and lipopolysaccharide testing specification for scientific projects requiring enhanced quality-control parameters.

View Safety Data Sheet